Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice (Q46072583)

19 December 2017

title

Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice (English)

1 reference

19 December 2017

main subject

ventricular remodeling

1 reference

Yiwen Li

1

1 reference

19 December 2017

Jianyong Wu

2

1 reference

19 December 2017

Qiang He

3

1 reference

19 December 2017

Zhangfei Shou

4

1 reference

19 December 2017

Ping Zhang

5

1 reference

19 December 2017

Wenhan Pen

6

1 reference

19 December 2017

Yilin Zhu

7

1 reference

19 December 2017

Jianghua Chen

8

1 reference

19 December 2017

language of work or name

1 reference

27 March 2009

1 reference

19 December 2017

published in

Hypertension Research

1 reference

19 December 2017

volume

32

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

369-374

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/hr.2009.25

exact match

0 references

cites work

Cardiovascular changes in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Left ventricular alterations and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Matrix metalloproteinases: regulation and dysregulation in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

The role of anti-cytokine therapy in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

ACE2 of the heart: From angiotensin I to angiotensin (1-7)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

Impact of left ventricular hypertrophy on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.25

7 January 2021

Identifiers

DOI

10.1038/HR.2009.25

1 reference

19 December 2017

Dimensions Publication ID

0 references

1 reference

19 December 2017